Pu-erh Tea Has In Vitro Anticancer Activity in TCA8113 Cells and Preventive Effects on Buccal Mucosa Cancer in U14 Cells Injected Mice In Vivo

REFERENCES

• Duh PD, Yen GC, Yen WJ, Wang BS, and Chang LW: Effects of Pu-erh tea on oxidative damage and nitric oxide scavenging. J Agric Food Chem 52, 8169–8176, 2004.
   PubMed Web of Science ®Google Scholar
• de Mejia EG, Ramirez-Mares MV, and Puangpraphant S: Bioactive components of tea: cancer, inflammation and behavior. Brain Behav Immun 23, 721–731, 2009.
   PubMed Web of Science ®Google Scholar
• Chen YS, Liu BL, and Chang YN: Bioactivities and sensory evaluation of Pu-erh teas made from three tea leaves in an improved pile fermentation process. J Biosci Bioeng 109, 557–563, 2010.
   PubMed Web of Science ®Google Scholar
• Zhang DY, Shao WF, Liu ZH, Liu YL, and Huang YW: Research on the anti-diabetes and anti-hyperlipidenmia function of monomers in Pu-erh tea. J Tea Sci 29, 41–46, 2009.
   Google Scholar
• Wu SC, Yen GC, Wang BS, Chiu CK, Yen WJ, Chang LW, and Duh PD: Antimutagenic and antimicrobial activities of Pu-erh tea. LWT-Food Sci Technol 40, 506–512, 2007.
   Web of Science ®Google Scholar
• Basu A and Lucas EA: Mechanisms and effects of green tea on cardiovascular health. Nutr Rev 65, 361–375, 2007.
   PubMed Web of Science ®Google Scholar
• Chan KP: First Step to Chinese Puerh Tea. Taipei, Taiwan: Wushing Books Press, 2004, p.17.
   Google Scholar
• Peng CZ, Liu C, and Li WY: Study on inoculated fermentation of Yunnan Puer tea. J Yunnan Univ (Nat Sci Edit) 30, 351–355, 2008.
   Google Scholar
• Zhu HT, Yang CR, Li Y, and Zhang YJ: Advances on the research of microbes during the post-fermentative process of Pu-Er tea. Acta Botanica Yunnanica 30, 718–724, 2008.
   Google Scholar
• Gong ZQ, Watanabe N, Yagi A, Etoh H, Sakata K, Ina K, and Liu QJ: Compositional change of Pu-erh tea during processing. Biosci Biotechnol Biochem 57, 1745–1746, 1993.
   PubMed Web of Science ®Google Scholar
• Jeng KC, Chen CS, Fang YP, Hou RCW, and Chen YS: Effect of microbial fermentation on content of statin, GABA, and polyphenols in Pu-erh tea. J Agri Food Chem 55, 8787–8792, 2007.
   PubMed Web of Science ®Google Scholar
• Zhou ZH and Yang CR: Chemical constituents of crude green tea, the material of Pu-er Tea in Yunnan. Acta Botanica Yunnanica 22, 343–350, 2000.
   Google Scholar
• Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, et al.: Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 48, 3282–3287, 1988.
   PubMed Web of Science ®Google Scholar
• Hsu SD, Singh BB, Lewis JB, Borke JL, Dickinson DP, et al.: Chemoprevention of oral cancer by green tea. Gen Dent 50, 140–146, 2002.
   PubMedGoogle Scholar
• Halder A, Raychowdhury R, Ghosh A, and De M: Black tea (Camellia sinensis) as a chemopreventive agent in oral precancerous lesions. J Environ Pathol Toxicol Oncol 24, 141–144, 2005.
   PubMed Web of Science ®Google Scholar
• Kolanjiappan K, Ramachandran CR, and Manoharan S: Biochemical changes in tumor tissues of oral cancer patients. Clin Biochem 36, 61–65, 2003.
   PubMed Web of Science ®Google Scholar
• Lee JS, Kim DH, Liu KH, Oh TK, and Lee CH: Identification of flavonoids using liquid chromatography with electrospray ionization and ion trap tandem mass spectrometry with an MS/MS library. Rapid Commun Mass Spectrom 19, 3539–3548, 2005.
   PubMed Web of Science ®Google Scholar
• Pang L, Qiu LH, Gao Z, Li P, Xu P, et al.: Experimental study on contrast-enhanced ultrasound imaging of metastatic lymph nodes of check carcinoma. J Clin Ultrasound Med 13, 581–583, 2011.
   Google Scholar
• Park JG, Kramer BS, Steinber CJ, Collins JM, Minna JD, et al.: Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium-based colorimetric assay. Cancer Res 47, 5875–5879, 1987.
   PubMed Web of Science ®Google Scholar
• Bak SS, Kong CS, Rhee SH, Rho CW, Kim NK, et al.: Effect of sulfur enriched Young Radish Kimchi on the induction of apoptosis in AGS human gastric adenocarcinoma cells. J Nutr Food Sci 12, 79–83, 2007.
   Google Scholar
• Kim YA, Rhee SH, Park KY, and Choi YH: Antiproliferative effect of resveratrol in human prostate carcinoma cells. J Med Food 6, 273–280, 2003.
   PubMedGoogle Scholar
• Schrader M and Laberke HG: Differential diagnosis of verrucous carcinoma in the oral cavity and larynx. J Laryngol Otol 102, 700–703, 1988.
   PubMed Web of Science ®Google Scholar
• Yang CS and Wang ZY: Tea and cancer. J Nat Cancer Inst 85, 1038–1049, 1993.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya A, Mandal D, Lahiry L, Sa G, and Das T: Black tea protects immunocytes from tumor-induced apoptosis by changing Bcl-2/Bax ratio. Cancer Lett 209, 147–154, 2004.
   PubMed Web of Science ®Google Scholar
• Sharmaa V, and Mohan RLJ: A thought on the biological activities of Black tea. Critical Rev Food Sci Nutr 49, 379–404, 2009.
   PubMed Web of Science ®Google Scholar
• Fujiki H, Suganuma M, Imai K, and Nakachi K: Green tea: cancer preventive beverage and/or drug. Cancer Lett 118, 9–13, 2002.
   Web of Science ®Google Scholar
• Lu QY, Yang YN, Jin YS, Zhang ZF, Heber D, et al.: Effects of green tea extract on lung cancer A549 cells: Proteomic identification of proteins associated with cell migration. Proteomics 9, 757–767, 2009.
   PubMed Web of Science ®Google Scholar
• Lee AH, Fraser ML, and Binns CW: Tea, coffee and prostate cancer. Mol Nutr Food Res 53, 256–265, 2009.
   PubMed Web of Science ®Google Scholar
• Yen GC, Duh PD, and Tsai HL: Antioxidant and pro-oxidant properties of ascorbic acid and gallic acid. Food Chem 79, 307–313, 2002.
   Web of Science ®Google Scholar
• Hofmann T and Altmann KH: Resorcylic acid lactones as new lead structures for kinase inhibition. Comptes Rendus Chimie 11, 1318–1335, 2008.
   Web of Science ®Google Scholar
• Yerma AK, Johnson JA, Gould MN, and Tanner MA: Inhibition of 7,12-Dimethylbenz(α)anthracene- and N-Nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin. Cancer Res 48, 5754–5758, 1988.
   PubMed Web of Science ®Google Scholar
• Nguyen TTT, Tran E, Ong CK, Lee SK, Do PT, et al.: Kaempferol-induced growth inhibition and apoptosis in A549 lung cancer cells is mediated by activation of MEK-MAPK. J Cell Physiol 197, 110–121, 2003.
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration: Guidance for Industry, Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. Silver Spring, MD: U.S. Author, 2005. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm078932.pdf
   Google Scholar
• Coussens LM and Werb Z: Inflammation and cancer. Nature 420, 860–867, 2002.
   PubMed Web of Science ®Google Scholar
• Li H, Wu WK, Li ZJ, Chan KM, Wong CC, et al.: 2,3′,4,4′,5′-Pentamethoxy-trans-stilbene, a resveratrol derivative, inhibits colitis-associated colorectal carcinogenesis in mice. Br J Pharmacol 160, 1352–1361, 2010.
   PubMed Web of Science ®Google Scholar
• Bai A and Peng Z: Biological therapies of inflammatory bowel disease. Immunotherapy 2, 727–742, 2010.
   PubMed Web of Science ®Google Scholar
• Perrier C and Rutgeerts P: Cytokine blockade in inflammatory bowel diseases. Immunotherapy 3, 1341–1352, 2011.
   PubMed Web of Science ®Google Scholar
• Malhotra R, Patel V, Vaqué JP, Gutkind JS, and Rusling JF: Ultrasensitive electrochemical immunosensor for oral cancer biomarker IL-6 using carbon nanotube forest electrodes and multilabel amplification. Anal Chem 82, 3118–3123, 2010
   PubMed Web of Science ®Google Scholar
• Engel MA, and Neurath MF: Anticancer properties of the IL-12 family: Focus on colorectal cancer. Curr Med Chem 17, 3303–3308, 2010.
   PubMed Web of Science ®Google Scholar
• Jablonska E, Piotrowski L, and Grabowska Z: Serum levels of IL-lβ, IL-6, TNF-α, sTNF-RI and CRP in patients with oral cavity cancer. Pathol Oncol Res 3, 126–129, 1997.
   PubMedGoogle Scholar
• Chao DT and Korsmeyer SJ: Bcl-2 family: regulators of cell death. Annu Rev Immunol 16, 395–419, 1998.
   PubMed Web of Science ®Google Scholar
• Song ZW and Steller H: Death by design: mechanism and control of apoptosis. Trends Cell Biol 15, 49–52, 1999.
   Web of Science ®Google Scholar
• Yang J, Liu XS, Bhalla K, Kim CN, Ibrado AM, Cai JY, Peng TI, Jones DP, and Wang XD: Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275, 1129–1132, 1997.
   PubMed Web of Science ®Google Scholar
• Chiang AC and Massagué J: Molecular basis of metastasis. New Engl J Med 359, 2814–2823, 2008.
   PubMed Web of Science ®Google Scholar
• Kleiner DE and Stetler-Stevenson WG: Matrix metalloproteinases and tumor metastasis. Cancer and Metast Reviews 25, 9–34, 2006.
   PubMed Web of Science ®Google Scholar
• Egeblad M and Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2, 161–174, 2002.
   PubMed Web of Science ®Google Scholar
• Krüger A, Fata JE, and Khokha R: Altered tumor growth and metastasis of a T-cell lymphoma in Timp-1 transgenic mice. Blood 90, 1993–2000, 1997.
   PubMed Web of Science ®Google Scholar
• Krüger A, Sanchez-Sweatman OH, Martin DC, Fata JE, Ho AT, et al.: Host TIMP-1 overexpression confers resistance to experimental brain metastasis of a fibrosarcoma cell line. Oncogene 16, 2419–2423, 1998.
   PubMed Web of Science ®Google Scholar